Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin (2017 - 2026)

Organogenesis Holdings has reported FCF Margin over the past 9 years, most recently at 15.41% for Q4 2025.

  • For Q4 2025, FCF Margin rose 943.0% year-over-year to 15.41%; the TTM value through Dec 2025 reached 4.34%, down 520.0%, while the annual FY2025 figure was 4.34%, 520.0% down from the prior year.
  • FCF Margin for Q4 2025 was 15.41% at Organogenesis Holdings, up from 0.56% in the prior quarter.
  • Over five years, FCF Margin peaked at 31.43% in Q4 2021 and troughed at 36.15% in Q2 2025.
  • A 5-year average of 0.12% and a median of 3.21% in 2024 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: surged 3330bps in 2021 and later plummeted -4922bps in 2022.
  • Year by year, FCF Margin stood at 31.43% in 2021, then plummeted by -157bps to 17.79% in 2022, then skyrocketed by 141bps to 7.32% in 2023, then decreased by -18bps to 5.98% in 2024, then surged by 158bps to 15.41% in 2025.
  • Business Quant data shows FCF Margin for ORGO at 15.41% in Q4 2025, 0.56% in Q3 2025, and 36.15% in Q2 2025.